Oculis Alternatives & Competitors
12 companies similar to Oculis — Oculis develops eye drops to treat ophthalmic diseases, improving patients' live...
Novaliq GmbH
Transforming Ocular Therapeutics
Vantage Biosciences
Transforming diabetic eye disease with an oral treatment
Tangible Science
Helping You Achieve Comfort and Success in Specialty Lenses!
OptiFit Fysiotherapie
Samen zorgen we voor uw optimale fitheid!
Track all Oculis competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
FimmCyte
First disease modifying treatment for Endometriosis.
iCare
Establishing the next level of eye care.
Phyteau, Inc.
Designed by Nature, Delivered by Science: A new class of incretin therapy for diabetes, ob...
Ability Biotherapeutics
Developing innovative targeted immuno therapeutics to addressing unmet medical needs for c...
INEYE THERAPEUTICS
Healthy eyes for a lifetime
Polytech Domilens GmbH
STARKE MARKEN FÜR IHREN ERFOLG
Advanced Foot And Ankle Care Centers
Complete Medical & Surgical Treatment of the Foot & Ankle
Otivio AS
About Oculis
Oculis develops eye drops to treat ophthalmic diseases, improving patients' lives worldwide.
Development of ophthalmic and neuro-ophthalmic treatments, Innovative pipeline and clinical trials, Transformative patient-centric solutions
Patients with diabetic macular edema, Patients with dry eye disease, Patients with optic neuritis, Medical professionals in ophthalmology and neuro-ophthalmology
Biopharmaceutical Company, Ophthalmic Diseases, Drug Delivery Platform, Diabetic Macular Edema, Cataract Surgery Inflammation, Dry Eye Disease, Anterior Uveitis, Acute Optic Neuritis, Topical Eye Drops, Neuroprotection, Anti-TNFα Biologics, Non-invasive Treatments, Innovative Product Pipeline, Ophthalmology Innovation, International Healthcare Investors
B2B, B2C, B2D
Product Sales, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Oculis and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Oculis on 6 May 2026. The 12 companies listed here were last checked between 26 Nov 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.